Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial (Q47605478)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial |
scientific article |
Statements
1 reference
Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial (English)
1 reference
Lars M Wagner
1 reference
Catherine A Billups
1 reference
Wayne L Furman
1 reference
Bhaskar N Rao
1 reference
Victor M Santana
1 reference
1 May 2004
1 reference
22
1 reference
10
1 reference
1886-1893
1 reference